6 employees
RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.
2010
$5.1M
from 2 investors over 2 rounds
RepliCel Life Sciences Inc. raised $2.1M on January 25, 2021
Investors: MainPointe Pharmaceuticals
RepliCel Life Sciences Inc. raised $5.1M on May 10, 2018
Investors: yofoto